The Interplay Between HIF‐1α and EZH2 in Lung Cancer and Dual‐Targeted Drug Therapy
Jianmin Wang(Ministry of Agriculture and Rural Affairs), Lihui Wang(Genedata (Switzerland))
Cited by 9
Related Papers
Genetic variation in selenoprotein S influences inflammatory response
|Nature Genetics|2005|378
Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity
|Cell Death and Disease|2017|134
Inactivation of <i>SMAD4</i> Tumor Suppressor Gene During Gastric Carcinoma Progression
|Clinical Cancer Research|2007|111
Point Mutation of the Proteasome β5 Subunit Gene Is an Important Mechanism of Bortezomib Resistance in Bortezomib-Selected Variants of Jurkat T Cell Lymphoblastic Lymphoma/Leukemia Line
|Journal of Pharmacology and Experimental Therapeutics|2008|107